Compounds > meglumine

meglumine and Neutropenia

meglumine has been researched along with Neutropenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badaró, F; Badaró, R; Carvalho, JS; Ho, JL; Johnson, WD; Jones, TC; Nascimento, C; Reed, SG; Russo, D2

Trials

2 trial(s) available for meglumine and Neutropenia

ArticleYear
Granulocyte-macrophage colony-stimulating factor in combination with pentavalent antimony for the treatment of visceral Leishmaniasis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1994, Volume: 13 Suppl 2

    Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Tests; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Neutropenia; Organometallic Compounds; Superinfection; Treatment Outcome

1994
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.
    The Journal of infectious diseases, 1994, Volume: 170, Issue:2

    Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Cross Infection; Double-Blind Method; Drug Therapy, Combination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Health Care Costs; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Neutropenia; Organometallic Compounds; Pilot Projects; Recombinant Proteins; Severity of Illness Index

1994